FI961584A0 - C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit - Google Patents

C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit

Info

Publication number
FI961584A0
FI961584A0 FI961584A FI961584A FI961584A0 FI 961584 A0 FI961584 A0 FI 961584A0 FI 961584 A FI961584 A FI 961584A FI 961584 A FI961584 A FI 961584A FI 961584 A0 FI961584 A0 FI 961584A0
Authority
FI
Finland
Prior art keywords
pct
reactive protein
protein fragments
oligopeptides derived
derived
Prior art date
Application number
FI961584A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961584A (fi
Inventor
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Massimo Pinori
Silvana Cappelletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of FI961584A0 publication Critical patent/FI961584A0/fi
Publication of FI961584A publication Critical patent/FI961584A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737C-reactive protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI961584A 1993-10-12 1996-04-11 C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit FI961584A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
PCT/EP1994/001574 WO1995010531A1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments

Publications (2)

Publication Number Publication Date
FI961584A0 true FI961584A0 (fi) 1996-04-11
FI961584A FI961584A (fi) 1996-04-11

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961584A FI961584A (fi) 1993-10-12 1996-04-11 C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit

Country Status (19)

Country Link
US (1) US6057295A (hu)
EP (1) EP0723552B1 (hu)
JP (1) JP3221881B2 (hu)
KR (1) KR100363408B1 (hu)
CN (1) CN1041524C (hu)
AT (1) ATE226591T1 (hu)
AU (1) AU684511B2 (hu)
CA (1) CA2173939C (hu)
DE (1) DE69431603T2 (hu)
DK (1) DK0723552T3 (hu)
ES (1) ES2185652T3 (hu)
FI (1) FI961584A (hu)
HU (1) HUT75538A (hu)
IL (1) IL109761A0 (hu)
IT (1) IT1271486B (hu)
NO (1) NO961423L (hu)
PT (1) PT723552E (hu)
WO (1) WO1995010531A1 (hu)
ZA (1) ZA943610B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (en) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidine derivatives useful in treatment of hepatitis C virus infection
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
JP5959440B2 (ja) 2010-01-19 2016-08-02 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 病原体の検出および治療のための改変オプソニン
JP2014523914A (ja) 2011-07-18 2014-09-18 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 操作された微生物標的化分子およびその使用
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHODS AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR CAPTURE OF A TARGET ENTITY
JP6649250B2 (ja) 2013-05-21 2020-02-19 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 操作されたヘム結合性構成物およびその使用
WO2015095604A2 (en) 2013-12-18 2015-06-25 President And Fellows Of Harvard College Methods and assays relating to circulating tumor cells
EP3331549B1 (en) 2015-08-06 2020-12-23 President and Fellows of Harvard College Improved microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0253190B1 (en) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
HU9600934D0 (en) 1996-08-28
CN1133048A (zh) 1996-10-09
AU6844194A (en) 1995-05-04
NO961423L (no) 1996-06-10
WO1995010531A1 (en) 1995-04-20
DE69431603T2 (de) 2003-03-13
JPH09503200A (ja) 1997-03-31
EP0723552A1 (en) 1996-07-31
CN1041524C (zh) 1999-01-06
DK0723552T3 (da) 2003-02-24
US6057295A (en) 2000-05-02
HUT75538A (en) 1997-05-28
IT1271486B (it) 1997-05-28
FI961584A (fi) 1996-04-11
CA2173939C (en) 2002-08-27
NO961423D0 (no) 1996-04-11
ITMI932154A0 (it) 1993-10-12
CA2173939A1 (en) 1995-04-20
DE69431603D1 (de) 2002-11-28
IL109761A0 (en) 1994-08-26
ZA943610B (en) 1995-01-25
ATE226591T1 (de) 2002-11-15
PT723552E (pt) 2003-02-28
EP0723552B1 (en) 2002-10-23
KR100363408B1 (ko) 2003-02-11
ITMI932154A1 (it) 1995-04-12
JP3221881B2 (ja) 2001-10-22
ES2185652T3 (es) 2003-05-01
AU684511B2 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
DE69727142D1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
SE8902532L (sv) Bestaemning av plasmaproteiner
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
ATE273388T1 (de) Veränderte menschliche c3-proteine
FI961584A0 (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
ATE218616T1 (de) Humanes zirkulierendes cytokin cc-1
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
EP1364657A4 (en) REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES
ATE316136T1 (de) Nierenpolycystose-gen
EA200001127A1 (ru) Бактериальные феромоны и их использование
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
EA199801032A1 (ru) Белки zona pellucida для контрацепции
LT2001045A (en) Compositions and use thereof for downmodulating the immune response to therapeutic proteins
ATE239499T1 (de) Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen
GB9723824D0 (en) Cytostatic agents

Legal Events

Date Code Title Description
FD Application lapsed